Management & Regulatory

Vensobafusp alfa seeks to redefine renal therapy by employing a bifunctional fusion protein that targets both the terminal and alternative complement pathways. For patients living with IgA nephropathy, the persistent threat of progressing toward end-stage renal disease remains a daunting reality

The perceived efficiency of telehealth on a spreadsheet frequently masks the invisible labor required to manage medication loops from a distance. For facilities like St. Vincent’s Hospital in Sydney, Australia, the transition to digital pharmaceutical services was not merely a technological upgrade

The journey from a laboratory breakthrough to a viable clinical product often represents a daunting hurdle that many medical technology innovators struggle to overcome without significant strategic support. The Korea Medical Device Development Fund, a significant cross-ministerial initiative

Evidence from German manufacturing facilities suggests that electrification can effectively eliminate direct emissions even if it temporarily increases purchased energy figures. This shift represents a fundamental transformation in how life sciences companies approach their environmental footprint

The recent events at the Irkutsk Anti-Plague Research Institute demonstrate the significant challenges of managing public perception during a potential highly virulent disease outbreak. When Darya Shipilova, a 27-year-old laboratory specialist, passed away on October 2, the localized incident

A fourteen-year prison sentence for a Cushing resident serves as a stark warning to those using sham telehealth visits to drive fraudulent medical claims. This legal outcome stems from an elaborate scheme that manipulated the digital healthcare landscape, leading to over thirty million dollars in